ELITE: Early Versus Late Intervention Trial With Estradiol
Status:
Completed
Trial end date:
2013-03-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of oral 17B-estradiol (estrogen) on the
progression of early (subclinical) atherosclerosis and cognitive decline in healthy
postmenopausal women.